BTK-IN-19

Modify Date: 2024-07-19 19:20:46

BTK-IN-19 structure	Common Name	BTK-IN-19
	CAS Number	1374240-01-3	Molecular Weight	445.34
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₁H₂₂Cl₂N₆O	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of BTK-IN-19

BTK-IN-19 (Compound 51) is a reversible BTK inhibitor with an IC50 of <0.001 μM[1].

Name	BTK-IN-19

Description	BTK-IN-19 (Compound 51) is a reversible BTK inhibitor with an IC50 of <0.001 μM[1].
Related Catalog	Research Areas >> Inflammation/Immunology Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Btk
Target	IC50: <0.001 μM (BTK)[1]
In Vitro	BTK-IN-19 (Compound 51) (3 days) inhibits B-cell proliferation with an IC50 of 0.080 μM[1].BTK-IN-19 (Compound 51) (3 days) 抑制 B 细胞增殖，IC50 为 0.080 μM[1]。 Cell Proliferation Assay[1] Cell Line: B cells enriched from PBMC Concentration: Incubation Time: 3 days Result: Inhibited B-cell proliferation with an IC50 of 0.080 μM.
In Vivo	BTK-IN-19 (Compound 51) (80 mg/kg; i.p.; once) 在小鼠中抑制 CD69[1]。 BTK-IN-19 (5 mg/kg; p.o.) 在大鼠中体内清除率低，具有适中的口服利用度 (%F > 34) [1]。 Animal Model: DBA/1 mice[1] Dosage: 80 mg/kg Administration: IP, once Result: Demonstrated strong inhibition of CD69.
References	[1]. Vandeveer GH, et al. Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model. Bioorg Med Chem Lett. 2022 Dec 17;80:129108.

Molecular Formula	C₂₁H₂₂Cl₂N₆O
Molecular Weight	445.34

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com